High levels of interleukin-6 in patients with rheumatoid arthritis are associated with greater improvements in health-related quality of life for sarilumab compared with adalimumab

Overview of attention for article published in Arthritis Research & Therapy, October 2020

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (80th percentile)
Good Attention Score compared to outputs of the same age and source (78th percentile)

Mentioned by

news: 1 news outlet

patent: 1 patent

Citations

dimensions_citation: 18 Dimensions

Readers on

mendeley: 83 Mendeley

Summary News Patents Dimensions citations

So far, Altmetric has seen 1 news story.

Sarilumab Shows Greater Improvements in QoL for Patients With RA and High Levels of IL-6

AJMC, 18 Dec 2020

Among patients with rheumatoid arthritis (RA) who have high levels of interleukin-6 (IL-6), treatment with sarilumab showed…

This page shows the most recent news stories that mention this research output.

Click here to find out how to access more activity.